These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31484280)

  • 61. Serial Stimulated Jitter Analysis In Juvenile Myasthenia Gravis.
    Bhatia S; Quinlan H; McCracken C; Price EW; Guglani L; Verma S
    Muscle Nerve; 2018 Nov; 58(5):729-732. PubMed ID: 30106469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis.
    Tomschik M; Renaud E; Jäger F; Paternostro C; Rath J; Rinner W; Zulehner G; Zimprich F; Cetin H
    Sci Rep; 2023 Feb; 13(1):2985. PubMed ID: 36806815
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Laryngeal myasthenia gravis: report of 40 cases.
    Mao VH; Abaza M; Spiegel JR; Mandel S; Hawkshaw M; Heuer RJ; Sataloff RT
    J Voice; 2001 Mar; 15(1):122-30. PubMed ID: 12269627
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Electromyogram from orbicularis oculi in normal persons and in patients with myasthenia gravis.
    BOTELHO SY; DEATERLY CF; COMROE JH
    AMA Arch Neurol Psychiatry; 1952 Mar; 67(3):348-53. PubMed ID: 14894005
    [No Abstract]   [Full Text] [Related]  

  • 65. Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography.
    Schwartz MS; Stålberg E
    Neurology; 1975 Jan; 25(1):80-4. PubMed ID: 1167410
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Facial muscular atrophy in a myasthenia gravis patient.
    Yuki N; Yoshioka A; Isayama R; Koizumi H; Nakagawa M
    Intern Med; 2008; 47(14):1355-7. PubMed ID: 18628586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interpretation of the repetitive nerve stimulation test results using principal component analysis.
    Cengiz B; Kuruoğlu HR
    Clin Neurophysiol; 2006 Sep; 117(9):2073-8. PubMed ID: 16890013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radial nerve repetitive stimulation in myasthenia gravis.
    Petretska A; Jarrar R; Rubin DI
    Muscle Nerve; 2006 Jun; 33(6):817-9. PubMed ID: 16555265
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Distinguishing Features of the Repetitive Nerve Stimulation Test Between Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis, 50-Year Reappraisal.
    Oh SJ
    J Clin Neuromuscul Dis; 2017 Dec; 19(2):66-75. PubMed ID: 29189551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparative study of single fiber electromyography and repetitive nerve stimulation in consecutive patients with myasthenia gravis.
    Srivastava A; Kalita J; Misra UK
    Electromyogr Clin Neurophysiol; 2007; 47(2):93-6. PubMed ID: 17479725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single fibre electromyographic studies in myasthenia gravis with repetitive nerve stimulation.
    Schwartz MS; Stålberg E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):678-82. PubMed ID: 1159439
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surrogate therapeutic outcome measures in patients with myasthenia gravis.
    Zinman L; Baryshnik D; Bril V
    Muscle Nerve; 2008 Feb; 37(2):172-6. PubMed ID: 17918748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic utility of stimulated single-fiber electromyography of the orbicularis oculi muscle in patients with suspected ocular myasthenia.
    Mercelis R; Merckaert V
    Muscle Nerve; 2011 Feb; 43(2):168-70. PubMed ID: 21254079
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?
    Sanders DB; Cao L; Massey JM; Juel VC; Hobson-Webb L; Guptill JT
    Clin Neurophysiol; 2014 Jun; 125(6):1274-7. PubMed ID: 24332471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reversible man-in-the-barrel syndrome in myasthenia gravis.
    Shah PA; Wadia PM
    Ann Indian Acad Neurol; 2016; 19(1):99-101. PubMed ID: 27011638
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical and electrophysiological characteristics of larynx in myasthenia gravis.
    Xu W; Han D; Hou L; Hu R; Wang L
    Ann Otol Rhinol Laryngol; 2009 Sep; 118(9):656-61. PubMed ID: 19810607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early-onset acquired myasthenia gravis secondary to anti-muscle-specific kinase autoantibodies.
    Yilmaz S; Gokben S; Serdaroglu G; Akcay A
    J Child Neurol; 2014 Jan; 29(1):108-10. PubMed ID: 23234677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.